TMCnet - World's Largest Communications and Technology Community



Research and Markets: Novartis - IMS Company Profiles - Gain a Comprehensive Picture of the Company's Strategic Direction
[January 21, 2013]

Research and Markets: Novartis - IMS Company Profiles - Gain a Comprehensive Picture of the Company's Strategic Direction

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "IMS Company Profiles:Novartis" company profile to their offering.

IMS Company Profiles gives a clear picture of the companies' strengths in terms of therapy areas and relevant marketed products as well as the future strategic direction of companies including R&D pipelines, analysts forecasts and events predicted to impact the future. Use IMS Company Profiles to:

- As a first step to any in-depth competitor analysis exercice

- Understand the influence of companies within therapy areas

- Evaluate the future drivers and potential constraints of companies

- Review independent analysts forecasts and commentaries

- Gain a comprehensive picture of a company's strategic direction

Key Topics Covered:

Corporate Structure

Strategy statement

Highlights a company's strengths / weaknesses and its potential for future growth. The strategy analysis gives you an insight into the following:

- M&A

- Regional strategies

- Therapeutic focus

- R&D strategy

- Licensing activities

- Commentary on future prospects, including brokers' overviews

- Interviewwith a key person (where available), including quotes and opinions

- Forecasting table (top 30 companies only), showing events with major potential impact

Financial Review

Company sales performance as well as analyst's comments and forecasts.

Company Sales Performance:

- Financial review

- Latest results

- Sales by geographical region & leading country

- Sales by country and subsidiary

- Analysis comments

Product Portfolio

Company Profiles reviews up to 40 products per company, whilst annual reports from the top 10 pharmaceutical companies cover up to a maximum of 10 drugs.

The section shows:

- Summary table of products facing patent expiry.

- Breakdown by relevant therapy area, within which, each product is discussed under the following headings: general, licensing, patents, clinical data, lifecycle management, competition and analysts' forecasts/comments.

R&D Pipelines

Comprehensive details of the projects that the company has in its R&D pipeline including:

- Research pipeline summary table.

- Introduction to the R&D activities of the company.

- Breakdown by relevant therapy area, within which, each project is detailed (up to 2 A4 pages), including information on clinical status and analysts' forecasts.

- Quotes from senior personnel gleaned from conferences may also be included in this section when available.

Key figures

- Sales by business segment.

- Sales by geographical region.

Analyst figures

IMS Sales data

- Pharmaceutical sales by geographical region and leading countries.

- Top 5 third level therapeutic classes.

- Leading international products

- Pharmaceutical sales analysis by age

Employee data

Licensing/Co-Marketing Agreements

Displayed in a tabular format to enable you to have at a glance review of the licensing activities of the company.

Three sections are available to review licensing activities:

- Marketed products

- R&D pipeline products

- General research collaborations, including combinatorial chemistry, proprietary technologies etc.

Major Events

Summary of the major events that have affected the company. This includes recent and historical events.

Two sections

- Mergers and Acquisitions

- Other major events

Events are organised in chronological order.

Subsidiaries listing

Mini-profile of each subsidiary that the company has worldwide showing address, major contacts and principal products.

For more information visit

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2017 Technology Marketing Corporation. All rights reserved | Privacy Policy